First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Financial Flexibility Index
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued financial flexibility index. First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (TRAXV) has a Financial Flexibility Index of -0.98x as of March 2026. Free cash flow of $-32.54 Million (operating CF $-32.56 Million minus capex $17.00K) represents -1% of total liabilities ($33.11 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued (2023–2024)
Financial flexibility index of First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued from 2023 to 2024. Historical Financial Flexibility Index trend for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued across 2 annual periods. Explore First Tracks Biotherapeutics, Inc. Ordin cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued Financial Flexibility Index by Year (2023–2024)
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued financial flexibility index by year from 2023 to 2024. Year-by-year free cash flow to debt coverage for First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued. For the full cash flow conversion analysis, see First Tracks Biotherapeutics, Inc. Ordin (TRAXV) cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.49x | $-125.45 Million | $-125.81 Million | $50.30 Million | ▲ +7.3% |
| 2023 | -2.69x | $-92.20 Million | $-93.00 Million | $34.26 Million | — |